期刊文献+

同种异体NK细胞对AML细胞体外杀伤活性及初步机制

Cytotoxicity of allogenetic natural killer cells against AML cells and molecular mechanism
下载PDF
导出
摘要 目的探讨同种异体自然杀伤细胞(NK细胞)对急性髓系白血病(AML)细胞株KG1a的杀伤活性及其分子机制。方法以NK敏感的K562细胞株为对照,免疫磁珠法分离5例健康志愿者NK细胞,乳酸脱氢酶(LDH)释放法测定在不同效靶比时NK细胞对KG1a细胞的杀伤活性,并用流式细胞仪检测KG1a细胞表面人类白细胞抗原I(HLA-I)类分子和NKG2D的配体主要组织相容性复合体(MIC)A/B、ULBP1-3的表达情况。结果效靶比1∶1、5∶1、10∶1、20∶1时NK细胞杀伤K562和KG1a细胞的活性不同,NK细胞对KG1a细胞的杀伤活性较K562细胞明显减低(P<0.01);K562细胞低表达HLA-I类分子,高表达NKG2D配体MIC可溶性Ⅰ类分子相关蛋白A(MICA)、MICA有亲源性的蛋白(MICB)、ULBP1、ULBP2、ULBP3,而KG1a细胞高表达HLA-I类分子,低表达NKG2D配体MICA、MICB、ULBP1、ULBP2、ULBP3。结论同种异体NK细胞对AML细胞株KG1a的杀伤率低于K562细胞;其杀伤率不同的分子基础与其分子表面配体表达差异和HLA-I分子表达率不同有关。 Objeetive To observe the cytotoxicity of allogenetic natural killer cellsagainst human acute myelocytic leukemia(AML) KGla cell line and its molecular mechanism.Methods The natural killer(NK) cells were isolated from 5 healthy individuals using magnetic cell sorting.The inhibitory effects of cytotoxicity of allogenetic NK cells against human acute myelogenous leukemia KGla cell line were measured by LDH re-lease assay.The expression of natural killer group 2 member D(NKG2D) ligauds(MICA/B,ULBP1,ULBP2,and ULBP3) and human leukocyte antigen(HLA) class I molecules on KG1a cells were assayed by flow cytometery.Results The inhibited the growth rate of KG1a vary with differ-ent effector-to-target.Conclusion NK cells inhibits the growth of KGla cells and up-regulated the expression of NKG2D ligands,and en-hances the sensitivity of KG1 cells to the cytotoxicity of NK cells.
出处 《临床和实验医学杂志》 2011年第16期1231-1232,共2页 Journal of Clinical and Experimental Medicine
基金 河南省教育厅资助课题2010A320012
关键词 NK细胞 KG1a细胞 NKG2D配体 HLA-I类分子 NK cell natural KG1a cells NKG2D ligand HLA class I molecules
  • 相关文献

参考文献7

  • 1Ruqqeri L, Mancusi A,Capanni M,et 8]. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer[J]. Curr Opin Immunol , 2005,17(2) :211 -217.
  • 2Bumett AK. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation - an adult treeaters view [J]. Br J Haematol , 2002,118(2) :357 -364.
  • 3Trinchieri G. The choices of a natural killer [J]. Nat Immunol ,2003,4 (6) :509 -510.
  • 4牛新清,胡亮杉,郭坤元,宋朝阳,涂三芳,梅家转.AS_2O_3对CD34^+白血病细胞NKG2D配体表达及NK杀伤活性的影响[J].中国免疫学杂志,2008,24(6):509-511. 被引量:8
  • 5Nowbakht P, Ionescu M C, Rohner Aet al. Ligands for natural killer cell - activating receptors are expressed upon the maturation of normal my- elomonocytic cells but at low levels in acute myeloid leukemias [ J ]. Blood, 2005,105(9) :3615 -3622.
  • 6Leung W,Iyenqar R, Turner V,et al. Determinats of antileukemia effects of allogenic NK cells[ J]. J Immunol, 2004,172( 1 ) :644 - 650.
  • 7Hasenkamp-- J, Borqerdiag A, Wulf G ,et ai. Resistance against natural killer cell cytotoxicity: analysis of mechanisms[ J]. Seand J Immunol, 2006,64(4) :444 -449.

二级参考文献13

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部